11 insiders reported 57 Form 4 transactions for GENELUX Corp (GNLX) over the past 18 months (most recent 2026-08-04). Recent activity: Yu Yong (Chief Scientific Officer) Sell 653 shares, Zindrick Thomas (President and CEO) Sell 3,023 shares, Cappello Joseph (Chief Technical Officer) Sell 653 shares, Smither John W (Director) Sell 12,000 shares, Pulisic Matthew (Chief Financial Officer) Buy 278,906 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-04 | Yu Yong | Chief Scientific Officer | Sell | 653 | $1,922 |
| 2026-08-04 | Zindrick Thomas | President and CEO | Sell | 3,023 | $8,905 |
| 2026-08-04 | Cappello Joseph | Chief Technical Officer | Sell | 653 | $1,924 |
| 2026-07-02 | Smither John W | Director | Sell | 12,000 | $34,898 |
| 2026-06-18 | Pulisic Matthew | Chief Financial Officer | Buy | 278,906 | $0 |
| 2026-06-18 | Tyree James L | Director | Buy | 28,409 | $0 |
| 2026-06-18 | Groen Eric | General Counsel | Buy | 233,957 | $0 |
| 2026-06-18 | Yu Yong | Chief Scientific Officer | Buy | 119,318 | $0 |
| 2026-06-18 | Mirabelli Mary | Director | Buy | 28,409 | $0 |
| 2026-06-18 | Zindrick Thomas | President and CEO | Buy | 730,601 | $0 |
| 2026-06-18 | Thomas John | Director | Buy | 28,409 | $0 |
| 2026-06-18 | Cappello Joseph | Chief Technical Officer | Buy | 174,841 | $0 |
| 2026-06-18 | Smither John W | Director | Buy | 28,409 | $0 |
| 2026-06-04 | Smalling Ralph | Head of Regulatory | Sell | 192 | $563 |
| 2026-06-02 | Thomas John | Director | Sell | 10,000 | $29,801 |
| 2026-05-12 | Yu Yong | Chief Scientific Officer | Sell | 605 | $1,798 |
| 2026-05-12 | Zindrick Thomas | President and CEO | Sell | 2,798 | $8,226 |
| 2026-05-12 | Cappello Joseph | Chief Technical Officer | Sell | 605 | $1,799 |
| 2026-05-12 | Smalling Ralph | Head of Regulatory | Sell | 270 | $804 |
| 2026-03-26 | Cappello Joseph | Chief Technical Officer | Sell | 906 | $2,193 |
| 2026-03-26 | Smalling Ralph | Head of Regulatory | Sell | 345 | $835 |
| 2026-03-26 | Smalling Ralph | Head of Regulatory | Sell | 240 | $602 |
| 2026-03-26 | Zindrick Thomas | President and CEO | Sell | 3,582 | $8,668 |
| 2026-03-26 | Yu Yong | SVP, Clinical Development | Sell | 906 | $2,193 |
| 2026-03-03 | Thomas John | Director | Sell | 10,000 | $29,000 |
Source: SEC Form 4 filings · as of 2026-08-04